HORIZON PHARMA PLC's ticker is HZNPXXXX and the CUSIP is G4617B105. A total of 243 filers reported holding HORIZON PHARMA PLC in Q4 2016. The put-call ratio across all filers is 0.35 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $511,000 | -84.0% | 19,350 | -88.1% | 0.02% | -81.9% |
| Q3 2018 | $3,190,000 | +18.2% | 162,900 | 0.0% | 0.12% | +13.7% |
| Q2 2018 | $2,698,000 | +16.6% | 162,900 | 0.0% | 0.10% | +13.3% |
| Q1 2018 | $2,313,000 | -2.7% | 162,900 | 0.0% | 0.09% | -2.2% |
| Q4 2017 | $2,378,000 | +15.1% | 162,900 | 0.0% | 0.09% | +24.3% |
| Q3 2017 | $2,066,000 | +6.8% | 162,900 | 0.0% | 0.07% | +2.8% |
| Q2 2017 | $1,934,000 | -19.7% | 162,900 | 0.0% | 0.07% | -22.6% |
| Q1 2017 | $2,408,000 | -8.6% | 162,900 | 0.0% | 0.09% | -17.0% |
| Q4 2016 | $2,636,000 | -80.6% | 162,900 | -78.3% | 0.11% | -78.6% |
| Q3 2016 | $13,596,000 | +10.1% | 749,900 | 0.0% | 0.52% | +3.8% |
| Q2 2016 | $12,351,000 | -0.6% | 749,900 | 0.0% | 0.50% | -4.5% |
| Q1 2016 | $12,426,000 | -23.5% | 749,900 | 0.0% | 0.53% | -10.4% |
| Q4 2015 | $16,250,000 | +151.6% | 749,900 | +130.2% | 0.59% | +153.9% |
| Q3 2015 | $6,458,000 | – | 325,800 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 5,959,819 | $96,430,000 | 10.71% |
| Consonance Capital Management LP | 5,793,903 | $93,745,000 | 10.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 8,956,988 | $144,924,000 | 5.96% |
| JW Asset Management, LLC | 507,075 | $8,205,000 | 5.46% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 6,682,618 | $108,125,000 | 5.23% |
| NEXTHERA CAPITAL LP | 500,000 | $8,090,000 | 4.74% |
| Lion Point Capital, LP | 1,164,414 | $18,840,000 | 4.58% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 4,503,900 | $72,873,000 | 3.52% |
| ARMISTICE CAPITAL, LLC | 650,000 | $10,517,000 | 2.49% |
| SCOPIA CAPITAL MANAGEMENT LP | 8,081,650 | $130,761,000 | 2.48% |